Stocks · Health care · Pharmaceutical Preparations

Aldeyra Therapeutics, Inc.

ALDX Clue Score54
United States Fiscal year ends December CIK 0001341235

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Todd C Brady
3 Jun 2026
President and CEO
Buy
250,000
$1.67
$418.45K
Richard Douglas
19 Mar 2026
Director
Buy
70,000
$1.40
$98.00K
Michael Alfieri
18 Mar 2026
Principal Financial Officer
Buy
5,000
$1.42
$7.10K

What was left out

Form 4 filings counted 11
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 5 May 2014